dacarbazine,pegfilgrastim,doxorubicin,nivolumab,brentuximab vedotin,vinblastine,filgrastim
amgen,bms,seagen
['nivo', 'cml']
#17icml nivo-avd vs bv-avd. presente by dr. herrera. more common neutropenia &amp; hypothyroidism in n-avd. more bone pain &amp; neuropathy in bv-avd. progression 0 for n-avd &amp; 1.2% in bv-avd. discontinue bv 22% &amp; n 11% pfs 1y n-94% bv-86%. efs 1y, n-91% vs bv 84%. 
Happily married. Hematologist & SC Transplanter. field of interest: lymphoma-myeloma &chemoresistance biomarkers. @HematoClinicBCN @hematosantpau.@GELL01433166